Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 7;41(46):4387-4388.
doi: 10.1093/eurheartj/ehaa934.

Conflicting results on the efficacy of remdesivir in hospitalized Covid-19 patients: comment on the Adaptive Covid-19 Treatment Trial

Leonarda Galiuto  1 , Carlo Patrono  2
Affiliations

Conflicting results on the efficacy of remdesivir in hospitalized Covid-19 patients: comment on the Adaptive Covid-19 Treatment Trial

Leonarda Galiuto et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

References

    1. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19—final report. N Engl J Med 2020. doi:10.1056/NEJMoa2007764. - PMC - PubMed
    1. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/ (9 October 2020). - PubMed
    1. Pan H, Peto R, Karim QA, Alejandria M, Henao Restrepo AM, Garcia CH, Kieny MP, Malekzadeh R, Murthy S, Preziosi MP, Reddy S, Roses M, Sathiyamoorthy V, Rottingen JA, Swaminathan S; WHO SOLIDARITY Trial Consortium. Repurposed antiviral drugs for COVID-19—interim WHO SOLIDARITY trial results. MedRxiv October 15, version. 10.1101/2020.10.15.20209817. - DOI - PMC - PubMed